Page last updated: 2024-12-08

glaucocalyxin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

glaucocalyxin B: chemical constituent of Rabdhosia japonica var. glaucocalyx [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14193399
CHEMBL ID563681
MeSH IDM0155337

Synonyms (7)

Synonym
glaucocalyxin b
CHEMBL563681
CS-6208
HY-N2113
[(1r,2r,4s,9r,10s,13s,16r)-2-hydroxy-5,5,9-trimethyl-14-methylidene-6,15-dioxo-16-tetracyclo[11.2.1.01,10.04,9]hexadecanyl] acetate
MS-26061
(1r,2r,4s,9r,10s,13s,16r)-2-hydroxy-5,5,9-trimethyl-14-methylidene-6,15-dioxotetracyclo[11.2.1.0,.0,hexadecan-16-yl acetate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID426930Cytotoxicity against human NB4 cells after 48 hrs by SRB method2009Journal of natural products, Jun, Volume: 72, Issue:6
ent-Kaurane diterpenoids from Isodon pharicus.
AID426931Cytotoxicity against human A549 cells after 48 hrs by SRB method2009Journal of natural products, Jun, Volume: 72, Issue:6
ent-Kaurane diterpenoids from Isodon pharicus.
AID426934Cytotoxicity against human MCF7 cells after 48 hrs by SRB method2009Journal of natural products, Jun, Volume: 72, Issue:6
ent-Kaurane diterpenoids from Isodon pharicus.
AID426933Cytotoxicity against human PC3 cells after 48 hrs by SRB method2009Journal of natural products, Jun, Volume: 72, Issue:6
ent-Kaurane diterpenoids from Isodon pharicus.
AID426932Cytotoxicity against human SH-SY5Y cells after 48 hrs by SRB method2009Journal of natural products, Jun, Volume: 72, Issue:6
ent-Kaurane diterpenoids from Isodon pharicus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]